Atlas Trials

177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

Clinical trial NCT06991738 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06991738
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Thyroid Cancer
Start date
2026-08-26
Primary completion
2032-07-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.